BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20261104T170000
DTEND;TZID=Australia/Sydney:20261104T170000
DTSTAMP:20260804T062313Z
CREATED:20260804T054341Z
LAST-MODIFIED:20260804T062313Z
UID:10000323-1793811600-1793811600@melanoma.org.au
SUMMARY:NHMRC Clinical Trials and Cohort Studies Grants
DESCRIPTION:Clinical Trials and Cohort Studies Grants support high-quality clinical trials and cohort studies that address important gaps in knowledge\, leading to relevant and implementable findings for the benefit of human health. \nThis funding scheme is open to research proposals for clinical trials and/or cohort studies of any size – that is\, they may be large or small clinical trials or cohort studies. \nThe intended outcomes of the Clinical Trials and Cohort Studies Grants scheme are improvements in health and well-being\, health care practice or policy\, as a result of: \n\nHigh-quality clinical trials that provide reliable evidence of the effects of health-related interventions on health outcomes (or appropriate surrogates).\nHigh-quality cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.\nHigh quality retrospective cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.\n\n\nKey Dates:\nApplications open: 9 September 2026\nMinimum data due date: 7 October 2026\nApplications close: 4 November 2026 \nGuidelines will be available when the grant opens. \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-clinical-trials-grants/
CATEGORIES:Grants,Clinical Trial Cohorts
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/07/NHMRC_Clinical_Trials_Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261105T170000
DTEND;TZID=America/Halifax:20261105T170000
DTSTAMP:20260804T054123Z
CREATED:20260804T054123Z
LAST-MODIFIED:20260804T054123Z
UID:10000325-1793898000-1793898000@melanoma.org.au
SUMMARY:Melanoma Research Alliance AWARDS
DESCRIPTION:The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical\, translational\, and early clinical research with the potential to produce unusually high impact\, near-term advancements in melanoma prevention\, detection\, diagnosis\, and treatment. \nThis cycle\, proposals will be accepted for Established Investigator Awards\, Academic-Industry Partnership Award (for Established Investigator Awards)\, Young Investigator Awards\, and Pilot Awards. \nMRA plans to support at least $7.9 million in new funding in the 2026-2027 cycle. \nSpecial Opportunities Included in RFP: \n\nAcral Melanoma Established Investigator\, Young Investigator\, and Pilot Awards focused on Advancing Translational Research for Acral Melanoma\nUveal Melanoma Established Investigator\, Young Investigator\, and Pilot Awards focused on Advancing Translational Research for Uveal Melanoma\nEstablished Investigator\, Young Investigator\, and Pilot Awards from applicants based in the United Kingdom (UK)\nEstablished Investigator\, Young Investigator\, and Pilot Awards from applicants based in Israel\n\n\nKey Dates: \n\nAugust 21\, 2026: Letters of Intent (LOI) due for Established Investigator Awards and Established Investigator Academic-Industry Partnership Award\nSeptember 14\, 2026: Eligibility Checklist and Biosketch due for Young Investigator Award applicants\nNovember 5\, 2026: Proposals due for Young Investigator and Pilot Awards\nDecember 10\, 2026: Invited Established Investigator Award full proposals due\nApril 2027: Awardees notified of funding decisions\nJune 1\, 2027: Project Start Date\n\nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mra-awards/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/08/Melanoma_Research_Alliance-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20261111T170000
DTEND;TZID=Australia/Sydney:20261111T170000
DTSTAMP:20260331T013110Z
CREATED:20260331T013110Z
LAST-MODIFIED:20260331T013110Z
UID:10000276-1794416400-1794416400@melanoma.org.au
SUMMARY:NHMRC Partnership Projects
DESCRIPTION:The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions\, undertake research\, interpret the findings and implement the findings into policy and practice. \n\nPartnership Projects create partnerships among decision makers\, policy makers\, managers\, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery\, organisation\, funding and access to health services. \nPartnership Projects will support collaborations\, within the Australian context\, that translate research evidence into health policy and health practice\, to improve health services and processes. \nThe objectives of the Partnership Project scheme are to: \n• Meet the need for more effective integration of research evidence into health policy and service delivery\n• Create partnerships among policy makers\, managers\, service providers and researchers\n• Provide support to answer often complex and difficult questions that policy makers\, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care\n• Be highly responsive to the priorities of government\, the community and health professionals\n• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations. \n\nKey Dates for Peer Review Cycle 2:\nApplications open: 19 March 2026\nNHMRC-approved Administering Institutions waiver due: 8 July 2026\nMinimum data due: 22 July 2026\nApplications close: 5 August 2026\nPeer review meetings: 17-19 November 2026 \nKey Dates for Peer Review Cycle 3:\nApplications open: 23 July 2026\nNHMRC-approved Administering Institutions waiver due: 14 October 2026\nMinimum data due: 28 October 2026\nApplications close: 11 November 2026\nPeer review meetings: 2-4 March 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-partnership-projects/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC-Partnership-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR